Keywords: teva, drops, challenge, oxycontin, patent, uk, mundipharma

Teva drops challenge to OxyContin patent

Article | 06 November 2006

Print This

The UK's Mundipharma International says it has strengthened its position with respect to European patents on its leading product, OxyContin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in